GK3, with its pivotal role in glycerol metabolism and triglyceride processing, is closely integrated with pathways responsible for cellular energy homeostasis and lipid metabolism. A quintessential player in this sphere is AMPK. Compounds like Acadesine and 5-Aminoimidazole-4-carboxamide riboside can activate AMPK, leading to shifts in cellular energy dynamics. These shifts affect glycerol metabolism, thereby indirectly modulating GK3's role. The resultant cascade of metabolic reactions underscores the importance of AMPK and its interplay with glycerol kinases like GK3.
Moreover, the domain of lipid metabolism, particularly triglyceride processing, cannot be overlooked. PPAR agonists, including Pioglitazone, Rosiglitazone, Bezafibrate, and Fenofibrate, stand out as central players. These compounds, upon activation of their respective PPAR isoforms, influence lipid metabolic processes that closely intertwine with GK3's function. Concurrently, the ATP-sensitive potassium channel opener, Minoxidil, provides a unique angle by affecting cellular energy states, adding another layer of complexity to the regulatory network. Glucocorticoids like Dexamethasone and sulfonylureas such as Glipizide, which influence glucose and lipid metabolism, can also leave their mark on the metabolic milieu, steering GK3's activity. The varied but interconnected roles of these chemicals paint a comprehensive picture of the intricate network governing GK3's function in cellular metabolism. Through this lens, the depth of GK3's interplay with various metabolic pathways becomes palpable, laying bare the multifaceted dynamics of glycerol and triglyceride metabolism.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
Activates AMPK, a key player in cellular energy homeostasis. By modulating AMPK, glycerol metabolism can be influenced, indirectly impacting GK3 activity. | ||||||
Pioglitazone hydrochloride | 112529-15-4 | sc-204848 sc-204848A | 100 mg 500 mg | $63.00 $213.00 | 19 | |
PPARγ agonist which affects lipid metabolism. PPARγ's activation can influence triglyceride processing, thereby potentially affecting GK3's function. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Another PPARγ agonist. By modulating lipid metabolism, it could indirectly influence the activity of GK3. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
A glucocorticoid affecting glucose and lipid metabolism. Its modulation of these processes can potentially have a downstream effect on GK3 activity. | ||||||
Bezafibrate | 41859-67-0 | sc-204650B sc-204650 sc-204650A sc-204650C | 500 mg 1 g 5 g 10 g | $31.00 $46.00 $122.00 $204.00 | 5 | |
PPAR agonist influencing lipid metabolism. By activating PPAR, it can modulate triglyceride metabolism, potentially affecting GK3's role in the process. | ||||||
Minoxidil (U-10858) | 38304-91-5 | sc-200984 sc-200984A | 100 mg 1 g | $69.00 $351.00 | ||
An ATP-sensitive potassium channel opener affecting cellular energy states. The resultant shifts in energy dynamics might indirectly modulate GK3 activity. | ||||||
GW 7647 | 265129-71-3 | sc-203068A sc-203068 sc-203068B sc-203068C | 1 mg 5 mg 10 mg 25 mg | $49.00 $170.00 $267.00 $661.00 | 6 | |
PPARα agonist, modulating lipid metabolism. Activation of PPARα can influence the glycerol-3-phosphate biosynthetic process, potentially impacting GK3. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
Influences AMPK activation, and through this action, affects cellular energy homeostasis. Such modulation might indirectly affect GK3 and its related processes. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $66.00 $267.00 | 2 | |
Lipid-lowering agent affecting lipid metabolism. By modulating lipid profiles, it might indirectly influence the role and activity of GK3. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
PPARα agonist impacting lipid metabolism. Its effect on triglyceride metabolism can indirectly influence the function and activity of GK3. | ||||||